<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Rogers HT</submitter><funding>NHLBI NIH HHS</funding><funding>Training  Program in Translational Cardiovascular Science</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><funding>National Science Foundation</funding><pubmed_abstract>Top-down-mass spectrometry (MS)-based proteomics has emerged as a premier technology to examine proteins at the proteoform level, enabling characterization of genetic mutations, alternative splicing, and post-translational modifications. However, significant challenges that remain in top-down proteomics include the analysis of large proteoforms and the sensitivity required to examine proteoforms from minimal amounts of sample. To address these challenges, we have developed a new method termed "&lt;u>s&lt;/u>mall-&lt;u>s&lt;/u>cale &lt;u>s&lt;/u>erial &lt;u>S&lt;/u>ize &lt;u>E&lt;/u>xclusion &lt;u>C&lt;/u>hromatography" (s&lt;sup>3&lt;/sup>SEC), which incorporates a small-scale protein extraction (1 mg of tissue) and serial SEC without postfractionation sample handling, coupled with online high sensitivity capillary reversed-phase </pubmed_abstract><journal>Analytical chemistry</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11298573</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Small-Scale Serial Size Exclusion Chromatography (s&lt;sup>3&lt;/sup>SEC) for High Sensitivity Top-Down Proteomics of Large Proteoforms.</pubmed_title><pmcid>PMC11298573</pmcid><funding_grant_id>R01 HL109810</funding_grant_id><funding_grant_id>T32 HL007936</funding_grant_id><funding_grant_id>R01 GM125085</funding_grant_id><funding_grant_id>DGE-1747503</funding_grant_id><funding_grant_id>S10 OD018475</funding_grant_id><funding_grant_id>R01 HL109810-06</funding_grant_id><funding_grant_id>T32 HL007936-21</funding_grant_id><funding_grant_id>R01 HL096971</funding_grant_id><pubmed_authors>Rogers HT</pubmed_authors><pubmed_authors>Larson EJ</pubmed_authors><pubmed_authors>Fischer MS</pubmed_authors><pubmed_authors>Rossler KJ</pubmed_authors><pubmed_authors>Ge Y</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Gao Z</pubmed_authors><pubmed_authors>Alpert AJ</pubmed_authors><pubmed_authors>Melby JA</pubmed_authors><pubmed_authors>Ehlers LE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Small-Scale Serial Size Exclusion Chromatography (s&lt;sup>3&lt;/sup>SEC) for High Sensitivity Top-Down Proteomics of Large Proteoforms.</name><description>Top-down-mass spectrometry (MS)-based proteomics has emerged as a premier technology to examine proteins at the proteoform level, enabling characterization of genetic mutations, alternative splicing, and post-translational modifications. However, significant challenges that remain in top-down proteomics include the analysis of large proteoforms and the sensitivity required to examine proteoforms from minimal amounts of sample. To address these challenges, we have developed a new method termed "&lt;u>s&lt;/u>mall-&lt;u>s&lt;/u>cale &lt;u>s&lt;/u>erial &lt;u>S&lt;/u>ize &lt;u>E&lt;/u>xclusion &lt;u>C&lt;/u>hromatography" (s&lt;sup>3&lt;/sup>SEC), which incorporates a small-scale protein extraction (1 mg of tissue) and serial SEC without postfractionation sample handling, coupled with online high sensitivity capillary reversed-phase </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-03-15T22:44:36.64Z</modification><creation>2025-08-13T03:06:34.219Z</creation></dates><accession>S-EPMC11298573</accession><cross_references><pubmed>38315630</pubmed><doi>10.1021/acs.analchem.3c05733</doi></cross_references></HashMap>